Hjem
Pascal Francois Gelebarts bilde

Pascal Francois Gelebart

Forsker
  • E-postpascal.gelebart@uib.no
  • Besøksadresse
    Haukeland universitetssykehus, Laboratoriebygget
    5009 Bergen
  • Postadresse
    Postboks 7804
    5020 Bergen
Vitenskapelig artikkel
  • Vis forfatter(e) (2024). Sarco/endoplasmic reticulum calcium ATPase 3 (SERCA3) expression in gastrointestinal stromal tumours. Pathology (Sydney).
  • Vis forfatter(e) (2023). Inhibition of a new AXL isoform, AXL3, induces apoptosis of mantle cell lymphoma cells. Blood. 1478-1493.
  • Vis forfatter(e) (2021). Gene Methylation and Silencing of WIF1 Is a Frequent Genetic Abnormality in Mantle Cell Lymphoma. International Journal of Molecular Sciences. 10 sider.
  • Vis forfatter(e) (2020). Stabilization of β-catenin upon B-cell receptor signaling promotes NF-kB target genes transcription in mantle cell lymphoma. Oncogene.
  • Vis forfatter(e) (2018). A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage. Nature Communications. 1-14.
  • Vis forfatter(e) (2016). Xenograft models of primary acute myeloid leukemia for the development of imaging strategies and evaluation of novel targeted therapies. Current Pharmaceutical Biotechnology. 42-51.
Vitenskapelig foredrag
  • Vis forfatter(e) (2022). Establishment of peritoneal dECM scaffolds for culture of ovarian cancer organoids.
  • Vis forfatter(e) (2022). Establishment of ovarian cancer organoids on peritoneal dECM scaffolds.
Mastergradsoppgave
  • Vis forfatter(e) (2018). Preclinical development of novel therapeutics in mantle cell lymphoma.
  • Vis forfatter(e) (2017). Exploration of novel therapeutic options in mantle cell lymphoma.
Brev til redaktøren
  • Vis forfatter(e) (2021). Preclinical characterisation and development of a novel myelodysplastic syndrome-derived cell line. British Journal of Haematology. 415-427.
Vitenskapelig Kapittel/Artikkel/Konferanseartikkel
  • Vis forfatter(e) (2022). Modeling the Tumor Microenvironment in Patient-Derived Xenografts: Challenges and Opportunities. 16 sider.
Poster
  • Vis forfatter(e) (2022). Establishment of peritoneal dECM scaffolds for 3D culture of ovarian cancer organoids.
Errata
  • Vis forfatter(e) (2023). Publisher Correction: A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage (Nature Communications, (2018), 9, 1, (1107), 10.1038/s41467-018-03441-3). Nature Communications.
  • Vis forfatter(e) (2018). Publisher Correction: A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage. Nature Communications.
Vitenskapelig oversiktsartikkel/review
  • Vis forfatter(e) (2020). Endoplasmic reticulum calcium pumps and tumor cell differentiation. International Journal of Molecular Sciences. 1-25.

Se fullstendig oversikt over publikasjoner i CRIStin.